Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11273998rdf:typepubmed:Citationlld:pubmed
pubmed-article:11273998lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C1522318lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C1515654lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C1304680lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C0205332lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C1261512lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C1532563lld:lifeskim
pubmed-article:11273998lifeskim:mentionsumls-concept:C0699795lld:lifeskim
pubmed-article:11273998pubmed:issue12lld:pubmed
pubmed-article:11273998pubmed:dateCreated2001-3-29lld:pubmed
pubmed-article:11273998pubmed:abstractTextLeukocyte attack (LA) and the triggered reactive proliferation of smooth muscle cells (SMCs) are key events for the development of early atherosclerosis and restenosis. In the present study, we used a 3D human coronary in vitro model of LA (3DLA model) to examine the effect of high-dose aspirin on the adhesion and chemotaxis of leukocytes and the reactive proliferative response of SMCs.lld:pubmed
pubmed-article:11273998pubmed:languageenglld:pubmed
pubmed-article:11273998pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:citationSubsetIMlld:pubmed
pubmed-article:11273998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11273998pubmed:statusMEDLINElld:pubmed
pubmed-article:11273998pubmed:monthMarlld:pubmed
pubmed-article:11273998pubmed:issn1524-4539lld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:FischerRRlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:BatzKKlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:HombachVVlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:KoenigWWlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:OsswaldMMlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:SungC CCClld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:VoisardRRlld:pubmed
pubmed-article:11273998pubmed:authorpubmed-author:VoglicSSlld:pubmed
pubmed-article:11273998pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11273998pubmed:day27lld:pubmed
pubmed-article:11273998pubmed:volume103lld:pubmed
pubmed-article:11273998pubmed:ownerNLMlld:pubmed
pubmed-article:11273998pubmed:authorsCompleteYlld:pubmed
pubmed-article:11273998pubmed:pagination1688-94lld:pubmed
pubmed-article:11273998pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:meshHeadingpubmed-meshheading:11273998...lld:pubmed
pubmed-article:11273998pubmed:year2001lld:pubmed
pubmed-article:11273998pubmed:articleTitleAspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model.lld:pubmed
pubmed-article:11273998pubmed:affiliationDepartment of Internal Medicine II, Division of Cardiology, University of Ulm, Germany. rainer.voisard@medizin.uni-ulm.delld:pubmed
pubmed-article:11273998pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11273998pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:11273998pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11273998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11273998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11273998lld:pubmed